HaiQing Dong

Prof. HaiQing Dong

Tongji University, Shanghai, China
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2022 in Advanced Science
Verified
Journal Article
Open access
FHFang Huang
Fang Huang
XLXiangyu Lu
Xiangyu Lu
YYYan Yang
Yan Yang
YYYushan Yang
Yushan Yang
YLYongyong Li
Yongyong Li
JSJianlin Shi
Jianlin Shi
Diabetic foot ulcers (DFU), one of the most serious complications of diabetes, are essentially chronic, nonhealing wounds caused by diabetic neuropathy, vascular disease, and bacterial infection. Given its pathogenesis, the DFU microenvironment is rather complicated and characterized by hyperglycemia, ischemia, hypoxia, hyperinflammation, and persistent infection. However, the current clinical therapies for DFU are dissatisfactory, which drives researchers to turn attention to advanced nanotechnology to address DFU therapeutic bottlenecks. In the last decade, a large number of multifunctional nanosystems based on the microenvironment of DFU have been developed with positive effects in DFU therapy, forming a novel concept of “DFU nanomedicine”. However, a systematic overview of DFU nanomedicine is still unavailable in the literature. This review summarizes the microenvironmental characteristics of DFU, presents the main progress of wound healing, and summaries the state‐of‐the‐art therapeutic strategies for DFU. Furthermore, the main challenges and future perspectives in this field are discussed and prospected, aiming to fuel and foster the development of DFU nanomedicines successfully.

11 November 2019 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
HWHuaiji Wang
Huaiji Wang
YLYing Liu
Ying Liu
RHRuiqing He
Ruiqing He
DXDailin Xu
Dailin Xu
JZJie Zang
Jie Zang
Yongyong LiYongyong Li
Yongyong Li
Nanoparticle capture and elimination by the immune system are great obstacles for drug delivery. Camouflaging nanoparticles with cell membrane represents a promising strategy to communicate and negotiate with the immune system. As a novel class of nanotherapeutics, such biomimetic nanoparticles inherit specific biological functionalities of the source cells (e.g., erythrocytes, immune cells, cancer cells and platelets) in order to evade immune elimination, prolong circulation time, and even target a disease region by virtue of the homing tendency of the cell membrane protein. In this review, we begin with an overview of different cell membranes that can be utilized to create a biointerface on nanoparticles. Subsequently, we elaborate on the state-of-the-art of cell membrane biomimetic nanoparticles for drug delivery. In particular, a summary of data on circulation capacity and targeting efficiency by camouflaged nanoparticles is presented. In addition to cancer therapy, inflammation treatment, as an emerging application of biomimetic nanoparticles, is specifically included. The challenges and outlook of this technology are discussed.

14 October 2011 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
HHHaiqing Hu
Haiqing Hu
JYJinhai Yu
Jinhai Yu
Yongyong LiYongyong Li
Yongyong Li
JZJian Zhao
Jian Zhao
HaiQing DongHaiQing Dong
HaiQing Dong

25 October 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
XLXiangyu Lu
Xiangyu Lu
LKLe Kuai
Le Kuai
FHFang Huang
Fang Huang
JJJingsi Jiang
Jingsi Jiang
JSJiankun Song
Jiankun Song
JSJianlin Shi
Jianlin Shi
Psoriasis is a common inflammatory disease of especially high recurrence rate (90%) which is suffered by approximately 3% of the world population. The overexpression of reactive oxygen species (ROS) plays a critical role in psoriasis progress. Here we show that biomimetic iron single-atom catalysts (FeN4O2-SACs) with broad-spectrum ROS scavenging capability can be used for psoriasis treatment and relapse prevention via related gene restoration. FeN4O2-SACs demonstrate attractive multiple enzyme-mimicking activities based on atomically dispersed Fe active structures, which are analogous to those of natural antioxidant enzymes, iron superoxide dismutase, human erythrocyte catalase, and ascorbate peroxidase. Further, in vitro and in vivo experiments show that FeN4O2-SACs can effectively ameliorate psoriasis-like symptoms and prevent the relapse with augmented efficacy compared with the clinical drug calcipotriol. Mechanistically, estrogen receptor 1 (ESR1) is identified as the core protein upregulated in psoriasis treatment through RNA sequencing and bioinformatic analysis. Together, this study provides a proof of concept of psoriasis catalytic therapy (PCT) and multienzyme-inspired bionics (MIB).

1 October 2008 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
HaiQing DongHaiQing Dong
HaiQing Dong
QXQi Xu
Qi Xu
Yongyong LiYongyong Li
Yongyong Li
SMShaobo Mo
Shaobo Mo
SCShaojun Cai
Shaojun Cai
LLLijian Liu
Lijian Liu

9 March 2022 in ACS Nano
Verified
Journal Article
Closed access
YLYao Liu
Yao Liu
YLYiping Lu
Yiping Lu
BNBo Ning
Bo Ning
XSXiaomin Su
Xiaomin Su
BYBinru Yang
Binru Yang
SSShun Shen
Shun Shen